Literature DB >> 31228614

Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer.

Bhagyashri Kulkarni1, Prathibha Kirave1, Piyush Gondaliya1, Kavya Jash1, Alok Jain1, Rakesh K Tekade2, Kiran Kalia3.   

Abstract

In the treatment of cancer, there are three significant limitations causing high mortality and recurrence rates among cancer patients. First, the escape of tumor cells from the immune system; second, the development of multi-drug resistance (MDR) to chemotherapeutic drugs; and, third, the noxious metastases of cancer cells. Exosomes are vesicular cargos involved in the transportation of miRNA, mRNA and proteins from one cell to another cell. This review details the current understanding of the exosomal transmission of miRNA and crosstalk with the downstream consequences, ultimately leading to the progression and metastasis of cancer. Further, this review also discusses how exosomal miRNA can provide promising novel targets for the treatment and detection of cancer.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31228614     DOI: 10.1016/j.drudis.2019.06.010

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  29 in total

1.  Exosomal Transfer of lncRNA H19 Promotes Erlotinib Resistance in Non-Small Cell Lung Cancer via miR-615-3p/ATG7 Axis.

Authors:  Rongtao Pan; Haiyan Zhou
Journal:  Cancer Manag Res       Date:  2020-06-08       Impact factor: 3.989

2.  Exosome-Derived miR-486-5p Regulates Cell Cycle, Proliferation and Metastasis in Lung Adenocarcinoma via Targeting NEK2.

Authors:  Huihui Hu; Hangdi Xu; Fen Lu; Jisong Zhang; Li Xu; Shan Xu; Hanliang Jiang; Qingxin Zeng; Enguo Chen; Zhengfu He
Journal:  Front Bioeng Biotechnol       Date:  2020-04-08

3.  STAT3 Regulates miR-384 Transcription During Th17 Polarization.

Authors:  Jingjing Han; Yaping Liu; Fei Zhen; Wen Yuan; Wei Zhang; Xiaotao Song; Fuxing Dong; Ruiqin Yao; Xuebin Qu
Journal:  Front Cell Dev Biol       Date:  2019-11-01

Review 4.  Exosomes and Their Noncoding RNA Cargo Are Emerging as New Modulators for Diabetes Mellitus.

Authors:  Wenguang Chang; Jianxun Wang
Journal:  Cells       Date:  2019-08-08       Impact factor: 6.600

Review 5.  Overview of microRNA-199a Regulation in Cancer.

Authors:  Qiwen Wang; Bingyu Ye; Ping Wang; Fenjie Yao; Chunyan Zhang; Guoying Yu
Journal:  Cancer Manag Res       Date:  2019-12-10       Impact factor: 3.989

6.  Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.

Authors:  Peng-Fei Zhang; Chao Gao; Xiao-Yong Huang; Jia-Cheng Lu; Xiao-Jun Guo; Guo-Ming Shi; Jia-Bin Cai; Ai-Wu Ke
Journal:  Mol Cancer       Date:  2020-06-27       Impact factor: 27.401

Review 7.  miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Hua Bai; Suhui Wu
Journal:  Onco Targets Ther       Date:  2019-12-16       Impact factor: 4.147

Review 8.  Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors.

Authors:  Pierre Autin; Christophe Blanquart; Delphine Fradin
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

9.  Circular RNA USP1 regulates the permeability of blood-tumour barrier via miR-194-5p/FLI1 axis.

Authors:  Yang Gao; Peiqi Wu; Yawen Ma; Yixue Xue; Yunhui Liu; Jian Zheng; Xiaobai Liu; Qianru He; Jun Ma; Libo Liu; Ping Wang
Journal:  J Cell Mol Med       Date:  2019-10-26       Impact factor: 5.310

10.  A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1.

Authors:  Diana Shah; Andrea Comba; Syed M Faisal; Padma Kadiyala; Gregory J Baker; Mahmoud S Alghamri; Robert Doherty; Daniel Zamler; Gabriel Nuñez; Maria G Castro; Pedro R Lowenstein
Journal:  Oncoimmunology       Date:  2021-06-28       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.